x

Search for a clinical trial

* (*) mandatory field

96 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member = ; Member of a ERN =

National clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

NETHERLANDS

Gelderland
NIJMEGEN

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberTreatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
Radboudumc - Radboud universitair medisch centrum
Polikliniek Kinderhemato-oncologie

FRANCE

HAUTS-DE-FRANCE
AMIENS

Recruiting trial
Ongoing trial
MAV-RAPA: Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
CHU Amiens-Picardie - Site Sud
Service de Chirurgie Maxillo-Faciale (CMF) et Stomatologie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Ongoing trial
AcSé : Secured Access to Pembrolizumab for Adult Patients With Selected Rare Cancer Types (Phase II)
CLCC Institut Gustave Roussy
Département d'Innovation Thérapeutique et d'Essais Précoces

GERMANY

Baden-Württemberg
STUTTGART

Ongoing trial
EURO-B.O.S.S.: A European treatment protocol for bone sarcoma in patients older than 40 years - DE
Klinikum Stuttgart - Standort Olgahospital
COSS (Cooperative OsteoSarkom Studiengruppe) Studienzentrale

ITALY

LAZIO
ROMA

Recruiting trial
Ongoing trial
A Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and/or Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway
IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
Ambulatorio Polispecialistico per le Malattie Rare

NETHERLANDS

Noord-Holland
AMSTERDAM

Recruiting trial
Ongoing trial
PropAngio study: Neoadjuvant Trial on the Efficacy of Propranolol Monotherapy in Cutaneous Angiosarcoma
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Medische Oncologie

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

SPAIN

Andalucía
SEVILLA

Recruiting trial
Ongoing trial
GEIS-52: Phase I-II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)

SPAIN

Cataluña
BADALONA

Recruiting trial
Ongoing trial
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Oncología Médica

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

CANADA

Ontario
TORONTO

FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Ongoing trial
METOGiA: MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de médecine interne et immunologie clinique

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
ITAC: Multicenter, Randomized, Prospective Trial Comparing the Efficacy and Safety of Infliximab to That of Cyclophosphamide in Severe Behçet's Disease.
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière
Département de Médecine Interne et Immunologie Clinique (DMIIC)

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
CHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCE

ILE-DE-FRANCE
PARIS

Ongoing trial
PEXIVAS: Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis: an International Randomized Controlled Trial (phase III) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

GERMANY

Bayern
REGENSBURG

Recruiting trial
Ongoing trial
Der Einfluss von Timolol Nasenspray auf Epistaxis bei Morbus Osler Patienten
Universitätsklinikum Regensburg
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde

NETHERLANDS

Utrecht
NIEUWEGEIN

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Recruiting trial
Ongoing trial
Rituximab and Belimumab Combination Therapy in PR3 COMBIVAS
Addenbrooke's Hospital
Addenbrookes Hospital

UNITED KINGDOM

Cambridgeshire
CAMBRIDGE

Ongoing trial
Funded by an IRDiRC memberBiologics in refractory vasculitis
University of Cambridge
Department of Medicine

UNITED KINGDOM

Greater London
LONDON

Recruiting trial
Ongoing trial
ENDURRANCE-1: Exploring durable remission with rituximab in ANCA associated vasculitis-GB
Imperial College London, main campus
Imperial College London Headquarters

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
Prospective, Multicenter, Single-arm Study to Assess the Safety and Performance of the BeGrow Stent System in Newborns and Infants to Treat Pulmonary Artery Stenosis - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Pädiatrische Kardiologie - Kinderherzzentrum Wien

FRANCE

ILE-DE-FRANCE
PARIS

Recruiting trial
Ongoing trial
ARCADE: Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome: a Double Blind, Randomized, Placebo Controlled, Multicenter Trial (Phase III) - FR
CHU Paris IdF Ouest - HEGP Hôpital Européen Georges Pompidou
Service de génétique - CR des Maladies Vasculaires Rares

ITALY

LOMBARDIA
PAVIA

Recruiting trial
Ongoing trial
Funded by an IRDiRC memberEffect of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilatation in patients with Marfan syndrome mutation carriers of the gene FBN1
Fondazione IRCCS Policlinico San Matteo
Laboratorio di Diagnostica Molecolare, Patologia Cardiovascolare e dei Trapianti

ITALY

PUGLIA
BARI

Recruiting trial
Ongoing trial
Combined Therapy With Peg-Interferon alpha, Ribavirin And Rituximab Of Hepatitis C Virus-Related Mixed Cryoglobulinemia - IT
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Unità di Epatologia - Sezione di Medicina Interna e Oncologia Clinica

NETHERLANDS

Groningen
GRONINGEN

Multinational clinical trial(s)

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US